Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Ischemic Heart Disease
Erythropoietin in Patients With Acute Coronary Syndrome and Its Cardioprotective Action After Percutaneous Coronary Intervention
Reo NakamuraAkihiko TakahashiTakeshi YamadaNobuyuki MiyaiHidekazu IrieNoriyuki KinoshitaTakahisa SawadaAkihiro AzumaHiroaki Matsubara
Author information
JOURNAL FREE ACCESS

2009 Volume 73 Issue 10 Pages 1920-1926

Details
Abstract

Background: Erythropoietin (EPO) has been shown to have effects beyond hematopoiesis, such as prevention of cardiac apoptosis. The purpose of the current study is to examine the influence of the time-course change in the serum concentration of endogenous EPO on cardiac functions in the chronic phase in patients with acute coronary syndrome, who successfully achieved reperfusion by primary percutaneous coronary intervention (PCI). Methods and Results: The prospective study included 34 patients with angiographically documented coronary artery disease, including 24 patients with acute myocardial infarction (AMI) and 10 patients with unstable angina pectoris (UAP) who underwent successful PCI within 24 h from the onset. Serum EPO concentration significantly increased at Day 3 and Day 7 compared with that at Day 1 in the AMI group, and the level at Day 3 was significantly higher in the AMI group than in the UAP group. There were significant correlations between ΔEPO and Δ left ventricular ejection fraction (LVEF) or Δ left ventricular end-diastolic volume index and between peak EPO concentration and ΔLVEF. Conclusions: These data showed the time-dependent increase of serum EPO in AMI patients after primary PCI, indicating its possible contribution to cardioprotective effect in the chronic phase. (Circ J 2009; 73: 1920-1926)

Content from these authors
© 2009 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top